CROSS-LINKED NUCLEOSIDE AND NUCLEOTIDE USING SAME

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230124641A1
SERIAL NO

17800339

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A cross-linked nucleoside of the present invention is a compound represented by the formula (I) below. The cross-linked nucleoside of the present invention is usable as a substitute for a phosphorothioate-modified nucleic acid, which has a risk of, for example, accumulation in a specific organ. The cross-linked nucleoside also has excellent industrial productivity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSAKA UNIVERSITYOSAKA
JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NATIONAL INSTITUTE OF HEALTH SCIENCES3-25-26 TONOMACHI KAWASAKI-KU KAWASAKI-SHI KANAGAWA 210-9501

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
INOUE, Takao Kawasaki-shi, Kanagawa, JP 204 3324
OBIKA, Satoshi Osaka, JP 50 1737
SAKURAI, Yota Osaka, JP 5 0
SUGITA, Kei Osaka, JP 3 9
YAMAGUCHI, Takao Osaka, JP 197 4627
YAMAMOTO, Chika Osaka, JP 5 32
YOSHIDA, Tokuyuki Kawasaki-shi, Kanagawa, JP 6 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation